Rhumbline Advisers Has $6.35 Million Position in Axcelis Technologies, Inc. (NASDAQ:ACLS)

Rhumbline Advisers grew its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 0.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 90,842 shares of the semiconductor company’s stock after purchasing an additional 477 shares during the quarter. Rhumbline Advisers’ holdings in Axcelis Technologies were worth $6,347,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in ACLS. Peterson Wealth Services grew its stake in shares of Axcelis Technologies by 12.7% in the 4th quarter. Peterson Wealth Services now owns 7,693 shares of the semiconductor company’s stock valued at $538,000 after buying an additional 868 shares during the period. Four Tree Island Advisory LLC bought a new position in shares of Axcelis Technologies in the fourth quarter valued at approximately $1,033,000. Empowered Funds LLC bought a new position in shares of Axcelis Technologies in the fourth quarter valued at approximately $465,000. Strategic Financial Concepts LLC purchased a new position in shares of Axcelis Technologies during the fourth quarter valued at approximately $727,000. Finally, Boston Trust Walden Corp grew its holdings in Axcelis Technologies by 61.9% during the fourth quarter. Boston Trust Walden Corp now owns 820,116 shares of the semiconductor company’s stock worth $57,302,000 after buying an additional 313,689 shares in the last quarter. 89.98% of the stock is owned by institutional investors.

Axcelis Technologies Price Performance

ACLS stock opened at $59.91 on Thursday. The firm has a 50 day simple moving average of $68.33 and a two-hundred day simple moving average of $84.42. The stock has a market cap of $1.95 billion, a PE ratio of 9.74, a P/E/G ratio of 4.52 and a beta of 1.52. Axcelis Technologies, Inc. has a one year low of $56.32 and a one year high of $158.61. The company has a debt-to-equity ratio of 0.04, a current ratio of 5.41 and a quick ratio of 4.05.

Axcelis Technologies (NASDAQ:ACLS) last announced its earnings results on Monday, February 10th. The semiconductor company reported $1.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.25 by $0.29. Axcelis Technologies had a net margin of 19.75% and a return on equity of 21.02%. On average, analysts predict that Axcelis Technologies, Inc. will post 2.55 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on ACLS shares. Benchmark cut shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Friday, November 8th. Craig Hallum dropped their price target on shares of Axcelis Technologies from $115.00 to $105.00 and set a “buy” rating on the stock in a research note on Wednesday, January 15th. William Blair cut Axcelis Technologies from an “outperform” rating to a “market perform” rating in a research report on Wednesday, February 12th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Axcelis Technologies in a report on Wednesday, February 12th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Axcelis Technologies currently has an average rating of “Hold” and an average price target of $154.00.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.